Skip to main content
Glama

Csv

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, idempotent), description discloses data sources (SEC EDGAR, FAERS), handling of off-calendar fiscal years, result sorting by primary metric, and return of citation URIs. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Efficiently packed with information: starts with query patterns, defines purpose, explains per-type behavior, details result format, and highlights efficiency. Every sentence adds value; no fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite lacking output schema, description adequately explains return format (paired data with citation URIs, sorted). Covers both entity types, edge cases (fiscal years), and entity count limits. Complete for a comparison tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% but description adds critical context: for company type it lists specific financial metrics (revenue, net income, etc.), for drug type it lists FAERS counts. Also clarifies value formats with examples (tickers vs drug names). Greatly enhances understanding.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states the tool performs side-by-side comparison of 2-5 entities (companies or drugs). It uses specific verbs like 'compare', 'rank', 'head-to-head' and distinguishes from siblings by noting it replaces 8-15 sequential lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' Provides example queries and specifies the type parameter determines data source (company vs drug). Effectively tells when to use without ambiguity.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Csv toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several tools overlap in purpose: ask_pipeworx_beta is explicitly identical to ask_pipeworx today, and the polymarket_* family plus bet_research all touch prediction-market analysis. The descriptions are extremely detailed and mostly disambiguate, but an agent must rely on very long text to avoid misselection.

Naming Consistency3/5

Names are almost all snake_case and readable, but the pattern is mixed: some are verb-first (resolve_entity, list_subscriptions), some noun-first (entity_profile, polymarket_edges), and some are one-word verbs (remember, forget). The ask_pipeworx_* and recent_* prefixes are consistent, but there is no single verb_noun convention throughout.

Tool Count2/5

33 tools is well over the 25+ threshold, especially for a server named 'Csv' that contains only two CSV-specific tools. The rest spans several unrelated domains: data research, prediction markets, subscriptions, memory, AI visibility, and package scanning. The set feels like multiple servers bundled together rather than one well-scoped surface.

Completeness4/5

As a broad data-research platform, coverage is strong: lookup, grounded answers, deep research, entity resolution, profiles, comparisons, fact-checking, subscription lifecycle, and memory persistence are all present. Minor gaps exist, such as no direct fetch tool for pipeworx:// citation URIs and no subscription-update tool, but most workflows have no dead ends.

Resources